Novonesis (Novozymes) B (FRA:NZM2)
€ 57.2 -0.14 (-0.24%) Market Cap: 26.58 Bil Enterprise Value: 28.31 Bil PE Ratio: 39.62 PB Ratio: 2.44 GF Score: 95/100

Novozymes A/S Spotlight on Human Health Presentation Transcript

Jun 17, 2022 / 12:00PM GMT
Release Date Price: €54.32 (-0.77%)
Operator

Presentation
Jun 17, 2022 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Ulrich Irgens

=====================
Conference Call Participants
=====================
* Alexander Jones
BofA Securities, Research Division - Analyst
* André Thormann
Danske Bank A/S, Research Division - Analyst
* Lars Topholm
Carnegie Investment Bank AB, Research Division - Co-Head of Research of Denmark & Financial Analyst

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot